The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2015

Filed:

Nov. 10, 2004
Applicants:

Frederik W. Van Ginkel, Auburn, AL (US);

David E. Briles, Birmingham, AL (US);

James M. Watt, Birmingham, AL (US);

Inventors:

Frederik W. Van Ginkel, Auburn, AL (US);

David E. Briles, Birmingham, AL (US);

James M. Watt, Birmingham, AL (US);

Assignee:

The UAB Research Foundation, Birmingham, AL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/09 (2006.01); C07K 16/12 (2006.01); C07K 16/40 (2006.01); C12N 9/24 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/092 (2013.01); C07K 16/1275 (2013.01); C07K 16/40 (2013.01); C12N 9/2402 (2013.01); C12Y 302/01018 (2013.01); A61K 38/00 (2013.01); A61K 2039/543 (2013.01); A61K 2039/55544 (2013.01);
Abstract

Provided herein are compositions designed to reduce or prevent bacterial infections (for example pneuomococcal infections), nasal carriage, nasal colonization, and central nervous system invasion. Provided herein is a composition comprising a pneumococcal neuraminidase, phosphocholine, pneumococcal teichoic acid, pneumococcal lipoteichoic acid, or an antigenic portion of either neuraminidase, phosphocholine, pneumococcal teichoic acid, pneumococcal lipoteichoic acid. Optionally, the composition can comprise any combination of a pneumococcal neuraminidase, a phosphocholine, a pneumococcal teichoic acid, a pneumococcal lipoteichoic acid or an antigenic portion of any one of these. Optionally the agents are detoxified. Further provided are methods of making and using the compositions disclosed herein. Specifically provided are methods of generating antibodies in a subject comprising administering to the subject an agent or composition taught herein. Also provided are methods of reducing or preventing nasal carriage or pneumococcal infection in a subject comprising administering to the subject a composition taught herein.


Find Patent Forward Citations

Loading…